Pharmala Biotech Holdings (MDMA) Stock Overview

Pharmala Biotech Holdings Inc., doing business as PharmAla, focuses on the developing, manufacturing, and commercializing of substituted methylenedioxy-phenethylamines (MDXX) active pharmaceutical ingredients. It also provides MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB); and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), as well as formulations of MDXX compounds. The company is headquartered in Vancouver, Canada.

MDMA Stock Information

Symbol

MDMA

Address

1111 Melville StreetVancouver, BC V6E 3V6Canada

Founded

Trading hours

Website

https://pharmala.ca

Country

🇨🇦 Canada

Phone Number

Pharmala Biotech Holdings (MDMA) Price Chart

Pharmala Biotech Holdings Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.173406395227856	N/A
Market Cap	$14.66M	N/A
Shares Outstanding	84.53M	5.98%
Employees	0	N/A
Shareholder Equity	1.38M	-27.42%

Valuation	2023	Change
P/E Ratio	-17.34	N/A
P/S Ratio	39.72	N/A
P/B Ratio	10.59	N/A

Growth	2023	Change
Return on Equity	-0.3910	N/A

Earnings	2023	Change
Revenue	$369.01K	N/A
Earnings	-$540.90K	N/A
EPS	-0.01	N/A
Earnings Yield	-0.0577	N/A
Gross Margin	0.8536	N/A
Operating Margin	-1.43	N/A
Net income margin	-1.47	N/A

Financial Strength	2023	Change
Total Assets	$1.67M	N/A
Cash on Hand	$135.29K	N/A
Debt to Equity	0.5159	234.57%
Current Ratio	0.6938	-72.91%